Outlook of China Drug Formulation Market
Product Description
It has been well recognized that the drug formulation has been one of the valued-added technologies for both innovative drugs and generics as well as both small molecule drugs and biologics. Although the drug formulation industry has existed in China for decades and growing numbers of Chinese drug companies are currently focusing on this area, their current technical skills and capability are still limited.
However, as the fast growing Chinese pharmaceutical market is providing great opportunities to all types of dosage form drugs, the Chinese drug formulation industry is also currently experiencing significant changes. The growth and development of this Chinese industry have thus started receiving attention of the drug companies from around the world.
The report, “Outlook of China Drug Formulation Market”, published by JZMed, Inc, a world renowned market research firm specialized in Chinese pharmaceutical and biotechnology industries, has provided a unique insight into the current development state of this Chinese industry.
The report analyzed, in both depth and detail, the Chinese drug formulation industry in all aspects including its current industry and market sizes, technical capabilities in drug formulation and the variety of dosage forms it can produce. Based on the in-depth analysis of a series of growth drivers and resistors that could affect the future development of this Chinese industry, the report also depicts a clear picture of what the Chinese industry will look like by 2015, including its development pattern and growth potential.
Moreover, by analyzing the current competitive landscape of the Chinese industry, the report also clearly revealed the roles currently played by the multinational drug companies in the Chinese market of finished drugs. Through a detailed, head-to-head comparison of the Chinese industry with its Indian counterpart in all aspects, the report also objectively revealed the current position of the Chinese industry in the global competitive landscape.
The report is a must-read book to all global pharmaceutical and biotechnology companies seeking marketing opportunities in China and collaboration with Chinese drug companies, venture capital investors interested in investment opportunities in the Chinese pharmaceutical industry, market research/consultancy companies seeking the information of the Chinese industry of finished drugs, and even the government agencies of those countries that are interested in learning the current and future development of the Chinese pharmaceutical industry.